Two studies have demonstrated that splenic myeloid-derived suppressor cells and regulatory T cells inhibit CD8+ T cell responses, promote tumor growth, and result in a poorer prognosis and fatigue in cancer patients (76, 77). This evidence concerns the gene CD8A and neoplasm.